A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS)

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2008

At a glance

  • Drugs Zileuton (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Apr 2008 The estimated date of final data collection for the primary endpoint has changed from June 2008 to May 2008 according to ClinicalTrials.gov.
    • 31 Mar 2008 Status change from recruiting to discontinued according to a media release from Critical Therapeutics.
    • 10 Jan 2008 The expected completion date for this trial is now 1 Jun 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top